Trial · NCT04991311
Registered outcomes27
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 27
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Absorption of Wet Weight/Fluids | from Week 0 (baseline) to Week 24 | Measured by 48-hour metabolic balance studies. The metabolic balance study measured the total intake and output of energy, macronutrients (lipids, carbohydrates, proteins) and micronutrients. The oral diet (food and fluids) was assessed by duplicate meals and liquids. During the metabolic balance study, the patients collected duplicate portions of all fluids and liquids covering 24-hour periods. Likewise, all output (ostomy output, diarrhea and urine production) was collected, quantified and analyzed. |
| Secondary | Change in Absorption of Energy | from Week 0 (baseline) to Week 24 | Oral intake minus fecal excretion: measured by 48-hour metabolic balance studies. The metabolic balance study measured the total intake and output of energy, macronutrients (lipids, carbohydrates, proteins) and micronutrients. The oral diet (food and fluids) was assessed by duplicate meals and liquids. During the metabolic balance study, the patients collected duplicate portions of all fluids and liquids covering 24-hour periods. Likewise, all output (ostomy output, diarrhea and urine production) was collected, quantified and analyzed. Energy absorption was measured by bomb calorimetry. |
| Secondary | Change in Absorption of Carbohydrates | from Week 0 (baseline) to Week 24 | Measured by 48-hour metabolic balance studies. The metabolic balance study measured the total intake and output of energy, macronutrients (lipids, carbohydrates, proteins) and micronutrients. The oral diet (food and fluids) was assessed by duplicate meals and liquids. During the metabolic balance study, the patients collected duplicate portions of all fluids and liquids covering 24-hour periods. Likewise, all output (ostomy output, diarrhea and urine production) was collected, quantified and analyzed. |
| Secondary | Change in Absorption of Lipids | from Week 0 (baseline) to Week 24 | Measured by 48-hour metabolic balance studies. The metabolic balance study measured the total intake and output of energy, macronutrients (lipids, carbohydrates, proteins) and micronutrients. The oral diet (food and fluids) was assessed by duplicate meals and liquids. During the metabolic balance study, the patients collected duplicate portions of all fluids and liquids covering 24-hour periods. Likewise, all output (ostomy output, diarrhea and urine production) was collected, quantified and analyzed. |
| Secondary | Change in Absorption of Proteins | from Week 0 (baseline) to Week 24 | Measured by 48-hour metabolic balance studies. The metabolic balance study measured the total intake and output of energy, macronutrients (lipids, carbohydrates, proteins) and micronutrients. The oral diet (food and fluids) was assessed by duplicate meals and liquids. During the metabolic balance study, the patients collected duplicate portions of all fluids and liquids covering 24-hour periods. Likewise, all output (ostomy output, diarrhea and urine production) was collected, quantified and analyzed. |
| Secondary | Change in Absorption of Sodium | from Week 0 (baseline) to Week 24 | Measured by 48-hour metabolic balance studies. The metabolic balance study measured the total intake and output of energy, macronutrients (lipids, carbohydrates, proteins) and micronutrients. The oral diet (food and fluids) was assessed by duplicate meals and liquids. During the metabolic balance study, the patients collected duplicate portions of all fluids and liquids covering 24-hour periods. Likewise, all output (ostomy output, diarrhea and urine production) was collected, quantified and analyzed. |
| Secondary | Change in Absorption of Potassium | from Week 0 (baseline) to Week 24 | Measured by 48-hour metabolic balance studies. The metabolic balance study measured the total intake and output of energy, macronutrients (lipids, carbohydrates, proteins) and micronutrients. The oral diet (food and fluids) was assessed by duplicate meals and liquids. During the metabolic balance study, the patients collected duplicate portions of all fluids and liquids covering 24-hour periods. Likewise, all output (ostomy output, diarrhea and urine production) was collected, quantified and analyzed. |
| Secondary | Change in Absorption of Calcium | from Week 0 (baseline) to Week 24 | Measured by 48-hour metabolic balance studies. The metabolic balance study measured the total intake and output of energy, macronutrients (lipids, carbohydrates, proteins) and micronutrients. The oral diet (food and fluids) was assessed by duplicate meals and liquids. During the metabolic balance study, the patients collected duplicate portions of all fluids and liquids covering 24-hour periods. Likewise, all output (ostomy output, diarrhea and urine production) was collected, quantified and analyzed. |
| Secondary | Change in Absorption of Magnesium | from Week 0 (baseline) to Week 24 | Measured by 48-hour metabolic balance studies. The metabolic balance study measured the total intake and output of energy, macronutrients (lipids, carbohydrates, proteins) and micronutrients. The oral diet (food and fluids) was assessed by duplicate meals and liquids. During the metabolic balance study, the patients collected duplicate portions of all fluids and liquids covering 24-hour periods. Likewise, all output (ostomy output, diarrhea and urine production) was collected, quantified and analyzed. |
| Secondary | Change in Weekly Parenteral Support (PS) Volume | from Week 0 (baseline) to Week 12 | Only for participants with Short Bowel Syndrome with Intestinal Failure (SBS-IF). PS use was recorded in patient diaries throughout the trial, including type and volume used. |
| Secondary | Change in Weekly PS Volume | from Week 0 (baseline) to Week 24 | Only for participants with SBS-IF. PS use was recorded in patient diaries throughout the trial, including type and volume used. |
| Secondary | Change in Weekly PS Carbohydrates | from Week 0 (baseline) to Week 12 | Only for participants with SBS-IF. PS use was recorded in patient diaries throughout the trial, including type and volume used. |
| Secondary | Change in Weekly PS Carbohydrates | from Week 0 (baseline) to Week 24 | Only for participants with SBS-IF. PS use was recorded in patient diaries throughout the trial, including type and volume used. |
| Secondary | Change in Weekly PS Lipids | from Week 0 (baseline) to Week 12 | Only for participants with SBS-IF. PS use was recorded in patient diaries throughout the trial, including type and volume used. |
| Secondary | Change in Weekly PS Lipids | from Week 0 (baseline) to Week 24 | Only for participants with SBS-IF. PS use was recorded in patient diaries throughout the trial, including type and volume used. |
| Secondary | Change in Weekly PS Proteins | from Week 0 (baseline) to Week 12 | Only for participants with SBS-IF. PS use was recorded in patient diaries throughout the trial, including type and volume used. |
| Secondary | Change in Weekly PS Proteins | from Week 0 (baseline) to Week 24 | Only for participants with SBS-IF. PS use was recorded in patient diaries throughout the trial, including type and volume used. |
| Secondary | Change in Weekly PS Sodium | from Week 0 (baseline) to Week 12 | Only for participants with SBS-IF. PS use was recorded in patient diaries throughout the trial, including type and volume used. |
| Secondary | Change in Weekly PS Sodium | from Week 0 (baseline) to Week 24 | Only for participants with SBS-IF. PS use was recorded in patient diaries throughout the trial, including type and volume used. |
| Secondary | Change in Weekly PS Potassium | from Week 0 (baseline) to Week 12 | Only for participants with SBS-IF. PS use was recorded in patient diaries throughout the trial, including type and volume used. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04991311/registered